Editorial Comment
Atrial Natriuretic Factor Is It Physiologically Important? John C. Burnett Jr., MD T he heart as an endocrine gland was unequivocally established with the ingenious experiments of DeBold and coworkers 1981 that demonstrated the existence of atrial natriuretic factor (ANF).1 These and subsequent studies have reported that ANF exists as a prepro-ANF molecule that is stored as a 126-amino-acid pro-ANF within atrial granules.2,3 In response to atrial stretch, pro-ANF is cleaved by a membrane-bound protease and released into the circulation as a 28-amino-acid peptide. 4 regulation of baroreceptor function. Is this physiological action an isolated action or does it have important and widespread functional significance?
Volpe and coworkers cogently speculate that elevation of endogenous ANF may have functional significance in congestive heart failure (CHF) by counteracting the impairment in the baroreceptormediated chronotropic reflex characteristic of heart failure.8 It is this hypothesis that may suggest the key physiological role for ANF. A support of this hypothesis is the observation that CHF is characterized by the highest concentrations of endogenous circulating ANF reported, which are concentrations of ANF with unequivocal physiological actions. 10 Lee et al recently proposed an important functional role for endogenous ANF in acute CHF.11 In a canine model of acute CHF produced by rapid ventricular pacing, cardiac output and arterial pressure were decreased in association with elevation of atrial pressures and plasma ANF. Despite the stimulus of arterial hypotension, sodium excretion was maintained and plasma renin and aldosterone were not increased. In contrast, reductions in arterial pressure to similar hypotensive levels in a low-cardiac output model of CHF produced by thoracic inferior vena caval constriction (TIVCC) was not associated with increases in atrial pressures or plasma ANF. In this latter model, plasma renin and aldosterone were markedly increased, and avid sodium retention was observed. When exogenous ANF was infused in dogs with TIVCC to mimic concentrations observed in the high-ANF pacing model of acute CHF, renin and aldosterone concentrations were normalized and sodium was not retained. The emerging important physiological role for endogenous ANF in acute and chronic CHF as a modulator of cardiovascular, renal, and endocrine function has therapeutic relevance. Acute intravenous administration of ANF in the intensive care unit as adjunct therapy in treatment of acute CHF may be indicated. Here, ANF may serve to limit tachycardia by modulating baroreceptor function together with an action to unload the heart, promote sodium excretion, and inhibit activation of the reninangiotensin-aldosterone system. In chronic CHF, the newly described agents that may promote the action of endogenous ANF by blocking its clearance at silent ANF clearance receptors16 or attenuating its metabolism by degradative enzymes17 may emerge as important therapeutic modalities.
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